MedTrace Logo

The Effect of Long-term Momordica Charantia Supplementation on Blood Glucose Levels

NCT05215210 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-11-07

No results posted yet for this study

Summary

The study is a parallel, double blind, controlled trial in which study participants will receive a 12-week intervention with 3.6 g/d dried bitter-gourd supplements or a reference intervention with 3.6 g/d dried cucumber supplements. Research subjects will come to the research facility for a test day on four occasions, with an interval of 4 weeks. The main study parameter is fasting levels of plasma glucose.

Conditions

  • Glucose, High Blood
  • Impaired Glucose Tolerance

Interventions

OTHER

Bitter-gourd

12-week intervention of 3.6 grams of dried bitter-gourd supplements

OTHER

Cucumber

12-week intervention of 3.6 grams of cucumber supplements

Sponsors & Collaborators

  • Wageningen University and Research

    lead OTHER

Principal Investigators

  • Sandra van der Haar, MSc · Stichting Wageningen Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-23
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05215210 on ClinicalTrials.gov